Cancer Drugs Market Report

Global and Region Cancer Drugs Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：191
  • REPORT CODE：GMM956945
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Cancer Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Cancer Drugsmarket, defines the market attractiveness level of Cancer Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Cancer Drugs industry, describes the types of Cancer Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Cancer Drugs market and the development prospects and opportunities of Cancer Drugs industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Cancer Drugs market in Chapter 13.

    By Player:

    • GlaxoSmithKline

    • Amgen

    • Bayer

    • Merck

    • Boehringer Ingelheim

    • Hoffmann-La Roche

    • Sanofi and Pfizer

    • Eli Lilly

    • Celgene Corporation

    • Bristol-Myers Squibb

    • Ariad Pharmaceuticals

    • Teva Pharmaceuticals

    • Novartis

    • Johnson and Johnson

    By Type:

    • Breast Cancer

    • Blood Cancer

    • Gastrointestinal Cancer

    • Prostate Cancer

    • Skin Cancer

    • Lung Cancer

    • Others

    By End-User:

    • Immunotherapy

    • Targeted Therapy

    • Chemotherapy

    • Hormone Therapy

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Cancer Drugs Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Cancer Drugs Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Cancer Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Cancer Drugs Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Cancer Drugs Market Analysis and Outlook to 2022

    • 7.1 Global Cancer Drugs Consumption (2017-2022)

    • 7.2 United States Cancer Drugs Consumption (2017-2022)

    • 7.3 Europe Cancer Drugs Consumption (2017-2022)

    • 7.4 China Cancer Drugs Consumption (2017-2022)

    • 7.5 Japan Cancer Drugs Consumption (2017-2022)

    • 7.6 India Cancer Drugs Consumption (2017-2022)

    • 7.7 South Korea Cancer Drugs Consumption (2017-2022)

    8 Region and Country-wise Cancer Drugs Market Analysis and Outlook to 2028

    • 8.1 Global Cancer Drugs Consumption Forecast (2022-2028)

    • 8.2 United States Cancer Drugs Consumption Forecast (2022-2028)

    • 8.3 Europe Cancer Drugs Consumption Forecast (2022-2028)

    • 8.4 China Cancer Drugs Consumption Forecast (2022-2028)

    • 8.5 Japan Cancer Drugs Consumption Forecast (2022-2028)

    • 8.6 India Cancer Drugs Consumption Forecast (2022-2028)

    • 8.7 South Korea Cancer Drugs Consumption Forecast (2022-2028)

    9 Global Cancer Drugs Market Outlook by Types and Applications to 2022

    • 9.1 Global Cancer Drugs Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Breast Cancer Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Blood Cancer Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Gastrointestinal Cancer Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Prostate Cancer Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Skin Cancer Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Lung Cancer Consumption and Growth Rate (2017-2022)

      • 9.1.7 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Cancer Drugs Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Immunotherapy Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Targeted Therapy Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Chemotherapy Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Hormone Therapy Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Cancer Drugs Market Outlook by Types and Applications to 2028

    • 10.1 Global Cancer Drugs Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Blood Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Gastrointestinal Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Skin Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.6 Global Lung Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.7 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Cancer Drugs Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Hormone Therapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Cancer Drugs Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Cancer Drugs Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Cancer Drugs Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Cancer Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Cancer Drugs Market Competitive Analysis

    • 14.1 GlaxoSmithKline

      • 14.1.1 GlaxoSmithKline Company Details

      • 14.1.2 GlaxoSmithKline Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 GlaxoSmithKline Cancer Drugs Product and Service

    • 14.2 Amgen

      • 14.2.1 Amgen Company Details

      • 14.2.2 Amgen Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Amgen Cancer Drugs Product and Service

    • 14.3 Bayer

      • 14.3.1 Bayer Company Details

      • 14.3.2 Bayer Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Bayer Cancer Drugs Product and Service

    • 14.4 Merck

      • 14.4.1 Merck Company Details

      • 14.4.2 Merck Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Merck Cancer Drugs Product and Service

    • 14.5 Boehringer Ingelheim

      • 14.5.1 Boehringer Ingelheim Company Details

      • 14.5.2 Boehringer Ingelheim Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Boehringer Ingelheim Cancer Drugs Product and Service

    • 14.6 Hoffmann-La Roche

      • 14.6.1 Hoffmann-La Roche Company Details

      • 14.6.2 Hoffmann-La Roche Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Hoffmann-La Roche Cancer Drugs Product and Service

    • 14.7 Sanofi and Pfizer

      • 14.7.1 Sanofi and Pfizer Company Details

      • 14.7.2 Sanofi and Pfizer Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Sanofi and Pfizer Cancer Drugs Product and Service

    • 14.8 Eli Lilly

      • 14.8.1 Eli Lilly Company Details

      • 14.8.2 Eli Lilly Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Eli Lilly Cancer Drugs Product and Service

    • 14.9 Celgene Corporation

      • 14.9.1 Celgene Corporation Company Details

      • 14.9.2 Celgene Corporation Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Celgene Corporation Cancer Drugs Product and Service

    • 14.10 Bristol-Myers Squibb

      • 14.10.1 Bristol-Myers Squibb Company Details

      • 14.10.2 Bristol-Myers Squibb Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Bristol-Myers Squibb Cancer Drugs Product and Service

    • 14.11 Ariad Pharmaceuticals

      • 14.11.1 Ariad Pharmaceuticals Company Details

      • 14.11.2 Ariad Pharmaceuticals Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Ariad Pharmaceuticals Cancer Drugs Product and Service

    • 14.12 Teva Pharmaceuticals

      • 14.12.1 Teva Pharmaceuticals Company Details

      • 14.12.2 Teva Pharmaceuticals Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Teva Pharmaceuticals Cancer Drugs Product and Service

    • 14.13 Novartis

      • 14.13.1 Novartis Company Details

      • 14.13.2 Novartis Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Novartis Cancer Drugs Product and Service

    • 14.14 Johnson and Johnson

      • 14.14.1 Johnson and Johnson Company Details

      • 14.14.2 Johnson and Johnson Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Johnson and Johnson Cancer Drugs Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Cancer Drugs

    • Figure Cancer Drugs Picture

    • Table Global Cancer Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Cancer Drugs Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Cancer Drugs Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Cancer Drugs Consumption by Country (2017-2022)

    • Figure United States Cancer Drugs Consumption and Growth Rate (2017-2022)

    • Table Europe Cancer Drugs Consumption and Growth Rate (2017-2022)

    • Figure China Cancer Drugs Consumption and Growth Rate (2017-2022)

    • Figure Japan Cancer Drugs Consumption and Growth Rate (2017-2022)

    • Figure India Cancer Drugs Consumption and Growth Rate (2017-2022)

    • Figure South Korea Cancer Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Cancer Drugs Consumption Forecast by Country (2022-2028)

    • Figure United States Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Breast Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Blood Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Gastrointestinal Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Prostate Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Skin Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Lung Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Immunotherapy Consumption and Growth Rate (2017-2022)

    • Figure Global Targeted Therapy Consumption and Growth Rate (2017-2022)

    • Figure Global Chemotherapy Consumption and Growth Rate (2017-2022)

    • Figure Global Hormone Therapy Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Blood Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Gastrointestinal Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Skin Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Lung Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Immunotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hormone Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Cancer Drugs Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Cancer Drugs Export by Region (Top 5 Countries) (2017-2028)

    • Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)

    • Table GlaxoSmithKline Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Cancer Drugs Product and Service

    • Table Amgen (Foundation Year, Company Profile and etc.)

    • Table Amgen Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amgen Cancer Drugs Product and Service

    • Table Bayer (Foundation Year, Company Profile and etc.)

    • Table Bayer Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer Cancer Drugs Product and Service

    • Table Merck (Foundation Year, Company Profile and etc.)

    • Table Merck Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Cancer Drugs Product and Service

    • Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)

    • Table Boehringer Ingelheim Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boehringer Ingelheim Cancer Drugs Product and Service

    • Table Hoffmann-La Roche (Foundation Year, Company Profile and etc.)

    • Table Hoffmann-La Roche Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hoffmann-La Roche Cancer Drugs Product and Service

    • Table Sanofi and Pfizer (Foundation Year, Company Profile and etc.)

    • Table Sanofi and Pfizer Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi and Pfizer Cancer Drugs Product and Service

    • Table Eli Lilly (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly Cancer Drugs Product and Service

    • Table Celgene Corporation (Foundation Year, Company Profile and etc.)

    • Table Celgene Corporation Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Celgene Corporation Cancer Drugs Product and Service

    • Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)

    • Table Bristol-Myers Squibb Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol-Myers Squibb Cancer Drugs Product and Service

    • Table Ariad Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Ariad Pharmaceuticals Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ariad Pharmaceuticals Cancer Drugs Product and Service

    • Table Teva Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Teva Pharmaceuticals Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Pharmaceuticals Cancer Drugs Product and Service

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Cancer Drugs Product and Service

    • Table Johnson and Johnson (Foundation Year, Company Profile and etc.)

    • Table Johnson and Johnson Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson and Johnson Cancer Drugs Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US